company background image
4534 logo

Mochida Pharmaceutical TSE:4534 Stock Report

Last Price


Market Cap







23 Jun, 2024


Company Financials +

Mochida Pharmaceutical Co., Ltd.

TSE:4534 Stock Report

Market Cap: JP¥108.8b

Mochida Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mochida Pharmaceutical
Historical stock prices
Current Share PriceJP¥3,070.00
52 Week HighJP¥3,465.00
52 Week LowJP¥2,863.00
11 Month Change3.89%
3 Month Change-5.10%
1 Year Change-6.69%
33 Year Change-16.69%
5 Year Change-33.04%
Change since IPO-21.06%

Recent News & Updates

Mochida Pharmaceutical's (TSE:4534) Dividend Will Be ¥40.00

Mar 22
Mochida Pharmaceutical's (TSE:4534) Dividend Will Be ¥40.00

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Mar 02
Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Recent updates

Mochida Pharmaceutical's (TSE:4534) Dividend Will Be ¥40.00

Mar 22
Mochida Pharmaceutical's (TSE:4534) Dividend Will Be ¥40.00

Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Mar 02
Mochida Pharmaceutical (TSE:4534) Will Pay A Dividend Of ¥40.00

Shareholder Returns

4534JP PharmaceuticalsJP Market

Return vs Industry: 4534 underperformed the JP Pharmaceuticals industry which returned 0.3% over the past year.

Return vs Market: 4534 underperformed the JP Market which returned 17.8% over the past year.

Price Volatility

Is 4534's price volatile compared to industry and market?
4534 volatility
4534 Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4534 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4534's weekly volatility (3%) has been stable over the past year.

About the Company


Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. The company offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology. It offers Lialda for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Lexapro, an antidepressant drug; Epadel drug for hyperlipidemia and arteriosclerosis obliterans; Urece for the treatment of gout and hyperuricemia; and Treprost for the treatment of pulmonary arterial hypertension.

Mochida Pharmaceutical Co., Ltd. Fundamentals Summary

How do Mochida Pharmaceutical's earnings and revenue compare to its market cap?
4534 fundamental statistics
Market capJP¥108.84b
Earnings (TTM)JP¥4.55b
Revenue (TTM)JP¥102.89b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4534 income statement (TTM)
Cost of RevenueJP¥50.82b
Gross ProfitJP¥52.07b
Other ExpensesJP¥47.52b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 02, 2024

Earnings per share (EPS)128.26
Gross Margin50.61%
Net Profit Margin4.42%
Debt/Equity Ratio0%

How did 4534 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.